
Sara Elizabeth Townsley
Examiner (ID: 5080, Phone: (571)270-7672 , Office: P/1629 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1629, 1612, 1613 |
| Total Applications | 512 |
| Issued Applications | 97 |
| Pending Applications | 84 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10499544
[patent_doc_number] => 09227937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-05
[patent_title] => 'Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning'
[patent_app_type] => utility
[patent_app_number] => 13/261513
[patent_app_country] => US
[patent_app_date] => 2011-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7519
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261513
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/261513 | Phenoxyalkyl pyridinium oxime therapeutics for treatment of organophosphate poisoning | May 11, 2011 | Issued |
Array
(
[id] => 8892263
[patent_doc_number] => 20130165446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/696978
[patent_app_country] => US
[patent_app_date] => 2011-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 116710
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13696978
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/696978 | BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE | May 10, 2011 | Abandoned |
Array
(
[id] => 10032612
[patent_doc_number] => 09073918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5'
[patent_app_type] => utility
[patent_app_number] => 13/697421
[patent_app_country] => US
[patent_app_date] => 2011-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61085
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13697421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/697421 | Pyrazolo[4,3-b]pyridine-7-amine inhibitors of ALK5 | May 9, 2011 | Issued |
Array
(
[id] => 8685127
[patent_doc_number] => 20130053411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 13/695628
[patent_app_country] => US
[patent_app_date] => 2011-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10053
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695628
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/695628 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING HYPERTENSION | Apr 28, 2011 | Abandoned |
Array
(
[id] => 8633382
[patent_doc_number] => 20130025185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-31
[patent_title] => 'CRAWLING INSECT BARRIER'
[patent_app_type] => utility
[patent_app_number] => 13/640508
[patent_app_country] => US
[patent_app_date] => 2011-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 2594
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640508
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/640508 | CRAWLING INSECT BARRIER | Apr 11, 2011 | Abandoned |
Array
(
[id] => 6166334
[patent_doc_number] => 20110173928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'PROCESS TO IMPROVE STABILITY OF A PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/074183
[patent_app_country] => US
[patent_app_date] => 2011-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2461
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20110173928.pdf
[firstpage_image] =>[orig_patent_app_number] => 13074183
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/074183 | PROCESS TO IMPROVE STABILITY OF A PHARMACEUTICAL COMPOSITION | Mar 28, 2011 | Abandoned |
Array
(
[id] => 8792745
[patent_doc_number] => 20130109714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/637538
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7626
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637538
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/637538 | NEURODEGENERATIVE DISEASE THERAPEUTIC AGENT | Mar 24, 2011 | Abandoned |
Array
(
[id] => 8416718
[patent_doc_number] => 20120244218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'Calcium supplement'
[patent_app_type] => utility
[patent_app_number] => 13/065643
[patent_app_country] => US
[patent_app_date] => 2011-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4693
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065643
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/065643 | Calcium supplement | Mar 24, 2011 | Abandoned |
Array
(
[id] => 10620542
[patent_doc_number] => 09339466
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Polymorphic forms of ST-246 and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 13/069813
[patent_app_country] => US
[patent_app_date] => 2011-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 18720
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13069813
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/069813 | Polymorphic forms of ST-246 and methods of preparation | Mar 22, 2011 | Issued |
Array
(
[id] => 7697053
[patent_doc_number] => 20110229537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'ORAL SUPPLEMENT'
[patent_app_type] => utility
[patent_app_number] => 13/050523
[patent_app_country] => US
[patent_app_date] => 2011-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4200
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229537.pdf
[firstpage_image] =>[orig_patent_app_number] => 13050523
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/050523 | ORAL SUPPLEMENT | Mar 16, 2011 | Abandoned |
Array
(
[id] => 6102207
[patent_doc_number] => 20110165700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'CLASSES OF COMPOUNDS THAT INTERACT WITH INTEGRINS'
[patent_app_type] => utility
[patent_app_number] => 13/047601
[patent_app_country] => US
[patent_app_date] => 2011-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5882
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165700.pdf
[firstpage_image] =>[orig_patent_app_number] => 13047601
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/047601 | CLASSES OF COMPOUNDS THAT INTERACT WITH INTEGRINS | Mar 13, 2011 | Abandoned |
Array
(
[id] => 5972595
[patent_doc_number] => 20110152228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE'
[patent_app_type] => utility
[patent_app_number] => 13/038483
[patent_app_country] => US
[patent_app_date] => 2011-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4925
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152228.pdf
[firstpage_image] =>[orig_patent_app_number] => 13038483
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/038483 | SPRAYABLE PHARMACEUTICAL COMPOSITIONS COMPRISING A CORTICOID AND AN OILY PHASE | Mar 1, 2011 | Abandoned |
Array
(
[id] => 8842007
[patent_doc_number] => 20130137635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/577755
[patent_app_country] => US
[patent_app_date] => 2011-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52462
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577755
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/577755 | TRYPTOPHAN HYDROXYLASE INHIBITORS FOR THE TREATMENT OF METASTATIC BONE DISEASE | Feb 8, 2011 | Abandoned |
Array
(
[id] => 7657316
[patent_doc_number] => 20110306585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Metal Complexes of N-Heterocyclic Carbenes'
[patent_app_type] => utility
[patent_app_number] => 13/021337
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16664
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306585.pdf
[firstpage_image] =>[orig_patent_app_number] => 13021337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/021337 | Metal complexes of N-heterocyclic carbenes | Feb 3, 2011 | Issued |
Array
(
[id] => 6055956
[patent_doc_number] => 20110112316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'TIGECYCLINE CRYSTALLINE FORMS AND PROCESSES FOR PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/006719
[patent_app_country] => US
[patent_app_date] => 2011-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4508
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112316.pdf
[firstpage_image] =>[orig_patent_app_number] => 13006719
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/006719 | Tigecycline crystalline forms and processes for preparation thereof | Jan 13, 2011 | Issued |
Array
(
[id] => 6121596
[patent_doc_number] => 20110077292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'FORSKOLIN CARBONATES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/973860
[patent_app_country] => US
[patent_app_date] => 2010-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4913
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077292.pdf
[firstpage_image] =>[orig_patent_app_number] => 12973860
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/973860 | FORSKOLIN CARBONATES AND USES THEREOF | Dec 19, 2010 | Abandoned |
Array
(
[id] => 6213908
[patent_doc_number] => 20110136750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/957555
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19273
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136750.pdf
[firstpage_image] =>[orig_patent_app_number] => 12957555
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/957555 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | Nov 30, 2010 | Abandoned |
Array
(
[id] => 6213907
[patent_doc_number] => 20110136749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/957551
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 19227
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136749.pdf
[firstpage_image] =>[orig_patent_app_number] => 12957551
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/957551 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | Nov 30, 2010 | Abandoned |
Array
(
[id] => 6033326
[patent_doc_number] => 20110082154
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-07
[patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery'
[patent_app_type] => utility
[patent_app_number] => 12/926594
[patent_app_country] => US
[patent_app_date] => 2010-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12488
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20110082154.pdf
[firstpage_image] =>[orig_patent_app_number] => 12926594
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/926594 | Sigma ligands for neuronal regeneration and functional recovery | Nov 28, 2010 | Abandoned |
Array
(
[id] => 10560634
[patent_doc_number] => 09284292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-15
[patent_title] => 'Sialochimeric compounds'
[patent_app_type] => utility
[patent_app_number] => 13/512306
[patent_app_country] => US
[patent_app_date] => 2010-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16369
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512306
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/512306 | Sialochimeric compounds | Nov 24, 2010 | Issued |